Category: Regulatory News

Ever wonder what really happens inside FTC headquarters? Us too! Join us during the 2022 Direct Selling Legal & Compliance Summit (DSLC) for a fascinating presentation from former FTC Commissioner Maureen Ohlhausen and former Director of Consumer Protection Andrew Smith. 

The FTC has published inflation-adjusted maximum civil penalty dollar amounts for violations in 2022.

Adding to this increased regulation are measures being taken by the U.S. Food & Drug Administration (FDA). Like other regulators, such as the Federal Trade Commission (FTC), the FDA is making a point of upping its game. While the FDA has always been an ardent protector of public health through its enforcement policies, they are adapting to new sales techniques by increasing their scrutiny of social media promotion.

In case you missed it - the full recording of the Social Selling News (SSN) Webinar: "The FTC Warning Letter: What Direct Sellers Should Know," which featured Momentum Factor CEO Jonathan Gilliam, is now available for you to watch.

Commissioner Christine Wilson of the Federal Trade Commission (FTC) recently criticized the FTC Chair's current agenda during an ABA Fall Forum speech. She spoke her mind regarding the commission's current course of action and predicted it would fall short of its goals while identifying four critical mistakes.

Momentum Factor CEO Jonathan Gilliam will be featured along with John Villafranco of Kelley Drye & Warren LLP on an upcoming Social Selling News (SSN) Webinar: "The FTC Warning Letter: What Direct Sellers Should Know." This important industry discussion will take place on Thursday, November 18 at 1 pm Central and will be hosted by SSN Publisher David Bland.

The Federal Trade Commission (FTC) has put more than 1,100 businesses, including many direct sales companies, on notice that if they deceive or mislead consumers about potential earnings, the agency may use its authority to target them with large civil penalties.

By successfully utilizing Section 19 of the FTC Act, the Federal Trade Commission has found a new avenue to restitution after Section 13(b) was vacated by the Fifth Circuit. An article from JD Supra details this important development.

Regulatory action is on the rise as the U.S. Food and Drug Administration and the Federal Trade Commission are coordinating consumer protection efforts.

The FDA and the FTC posted warning letters to 10 companies for illegally selling dietary supplements that claim to cure, treat, mitigate, or prevent diabetes, in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act).